CNTG logo

Centogene NV (CNTG) Company Overview

Profile

Full Name:

Centogene N.V.

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

Germany

IPO:

November 7, 2019

Indexes:

Not included

Website:

http://www.centogene.com

Description:

Centogene NV (CNTG) is a biotechnology company that focuses on genetic testing and rare disease research. They provide diagnostic solutions and data analysis to help identify genetic disorders, enabling better patient care and treatment options. Their work supports healthcare professionals in understanding complex genetic conditions.

Key Details

Price

$0.14

Market Cap

$4.07 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$52.55 M(+4.95% YoY)

Annual EPS

-$1.37(-9.55% YoY)

PE Ratio

-

Annual ROE

137.65%

Annual Debt To Equity

-2.60

Beta

0.40

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Sep 6, 2024

Recent annual earnings:

Jan 18, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jun 28, 23 HC Wainwright & Co.
Buy
May 18, 23 HC Wainwright & Co.
Buy
Apr 27, 23 HC Wainwright & Co.
Buy
Apr 13, 23 HC Wainwright & Co.
Buy
Apr 12, 23 HC Wainwright & Co.
Buy
Feb 22, 23 HC Wainwright & Co.
Buy
Jan 17, 23 HC Wainwright & Co.
Buy
Nov 23, 22 HC Wainwright & Co.
Buy
Jul 18, 22 SVB Leerink
Outperform
Jun 17, 21 Credit Suisse
Outperform

Screeners with CNTG included

Stocks cheaper than 1 dollar
Stocks below SMA 200
Best performing stocks last 3 months
Healthcare sector
All stocks
Small cap stocks
Stocks with low beta
Diagnostics & Research industry
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.14
CNTG price is $0.14

Price All-time High

$25.16
CNTG price is currently -99.44% below its historical high of $25.16

Price Analysts Target

-
CNTG price consensus analysts' forecast is unknown

Price Most Recent Change

0%
CNTG {parameterFullLabel} has remained unchanged on Feb 27, 2025

Price YTD Change

+3.47%
CNTG price is up +3.47% since January 1st

Price 3-Year Change

-96.37%
CNTG price is down -96.37% over the past 3 years

Market cap

Market Cap

$4.07 M
CNTG market capitalization is $4.07 million

Market Cap 3-Year Change

-96.11%
CNTG market capitalization is down -96.11% over the past 3 years

Market Cap All-time High

$499.71 M
CNTG market capitalization is currently -99.19% below its historical high of $499.71 million

Market Cap Sector Rank

11.01%
CNTG market capitalization is higher than 11.01% of companies in Healthcare sector

Technical

Beta

0.40
CNTG beta is 0.40

200-day SMA

$0.23
CNTG price is currently -38.03% below its 200-day simple moving average

14-day RSI

48.00
CNTG 14-day relative strength index is 48.00

30-day Relative Volume

0.00
CNTG 30-day relative volume is 0.00

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$52.55 M
CNTG annual revenue is $52.55 million

Annual Revenue Analysts Estimate

$64.79 M
CNTG annual revenue is currently -18.90% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+4.95%
CNTG annual revenue is up +4.95% year-on-year

Annual Revenue Sector Rank

47.85%
CNTG annual revenue is higher than 47.85% of companies in Healthcare sector

Profit

Annual Gross Profit

$18.67 M
CNTG annual gross profit is $18.67 million

Annual Gross Margin

35.54%
CNTG annual gross profit margin is 35.54%

Annual Operating Profit

-$39.00 M
CNTG annual operating income is -$39.00 million

Annual Operating Margin

-74.22%
CNTG annual operating profit margin is -74.22%

Annual Net Income

-$38.47 M
CNTG annual net profit is -$38.47 million

Annual Net Margin

-73.21%
CNTG annual net profit margin is -73.21%

EPS

Annual EPS

-$1.37
CNTG annual earnings per share is -$1.37

Annual EPS Analysts Estimate

-
CNTG annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-9.55%
CNTG annual earnings per share is down -9.55% year-on-year

Annual EPS Sector Rank

52.02%
CNTG annual earnings per share is higher than 52.02% of companies in Healthcare sector

ROA & ROE

Annual ROA

-41.63%
CNTG annual return on assets is -41.63%

Annual ROE

137.65%
CNTG annual return on equity is 137.65%

EBIT & EBITDA

Annual EBIT

-$29.28 M
CNTG annual earnings before interest & taxes is -$29.28 million

Annual EBITDA

-$21.04 M
CNTG annual EBITDA is -$21.04 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
CNTG price to earnings ratio value is unknown

PE Ratio Sector Rank

-
CNTG price to earnings ratio is unknown

PB Ratio

PB Ratio

-0.15
CNTG price to book ratio is -0.15

PB Ratio Sector Rank

13.06%
CNTG price to book ratio is higher than 13.06% of companies in Healthcare sector

PS Ratio

PS Ratio

-
CNTG price to sales ratio value is unknown

PS Ratio Sector Rank

-
CNTG price to sales ratio is unknown

Enterprise value

Enterprise Value

$72.79 M
CNTG enterprise value is $72.79 million

Enterprise Value Sector Rank

44.97%
CNTG enterprise value is higher than 44.97% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
CNTG EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
CNTG EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.02
CNTG annual current ratio is 1.02

Annual Quick Ratio

0.96
CNTG annual quick ratio is 0.96

Leverage

Annual Debt To Equity

-2.60
CNTG annual debt to equity ratio is -2.60

Annual Interest Coverage Ratio

-3.30
CNTG annual interest coverage ratio is -3.30

Risk & Stability

Piotroski F-Score

-
CNTG piotroski f-score value is unknown

Altman Z-Score

-3.70
CNTG altman z-score is -3.70

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$85.29 M
CNTG annual total assets is $85.29 million

Annual Non Current Assets

$36.63 M
CNTG annual long term assets is $36.63 million

Annual Current Assets

$48.66 M
CNTG annual total current assets is $48.66 million

Annual Cash & Cash Equivalents

$20.09 M
CNTG annual cash & cash equivalents is $20.09 million

Equity

Annual Book Value

-$27.95 M
CNTG annual book value is -$27.95 million

Annual Working Capital

$721.80 K
CNTG annual working capital is $721.80 thousand

Liabilities

Annual Total Liabilities

$113.23 M
CNTG annual total liabilities is $113.23 million

Annual Total Long Term Liabilities

$65.30 M
CNTG annual total long term liabilities is $65.30 million

Annual Current Liabilities

$47.94 M
CNTG annual total current liabilities is $47.94 million

Annual Accounts Payable

$6.22 M
CNTG annual accounts payable is $6.22 million

Debt

Annual Total Debt

$88.81 M
CNTG annual total debt is $88.81 million

Annual Total Debt 1-Year Change

+37.74%
CNTG annual total debt is up +37.74% year-on-year

Annual Long Term Debt

$57.79 M
CNTG annual long term debt is $57.79 million

Annual Short Term Debt

$31.02 M
CNTG annual short term debt is $31.02 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$91.54 M
CNTG annual total expenses is $91.54 million

Annual Operating Expenses

$57.67 M
CNTG annual total operating expenses is $57.67 million

Annual Cost Of Goods Sold

$33.87 M
CNTG annual cost of goods sold is $33.87 million

Annual SGA

$45.18 M
CNTG annual SGA is $45.18 million

Annual D&A

$8.24 M
CNTG annual depreciation & amortization is $8.24 million

Annual Interest Expense

$8.88 M
CNTG annual interest expense is $8.88 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$34.37 M
CNTG annual cash flow from operations is -$34.37 million

Annual CFO 1-Year Change

-23.05%
CNTG annual cash flow from operations is down -23.05% year-on-year

Annual CFI

$2.47 M
CNTG annual cash flow from investing activities is $2.47 million

Annual CFI 1-Year Change

+418.9%
CNTG annual cash flow from investing activities is up +418.9% year-on-year

Annual CFF

$14.12 M
CNTG annual cash flow from financing activities is $14.12 million

Annual CFF 1-Year Change

-71.09%
CNTG annual cash flow from financing activities is down -71.09% year-on-year

Free CashFlow

Annual FCF

-$36.84 M
CNTG annual free cash flow is -$36.84 million

Annual FCF 1-Year Change

-22.22%
CNTG annual free cash flow is down -22.22% year-on-year

CAPEX

Annual CAPEX

$2.47 M
CNTG annual capital expenditures is $2.47 million

Annual CAPEX 1-Year Change

+11.73%
CNTG annual capital expenditures is up +11.73% year-on-year

Institutional Ownership

Similar stocks

NIVF logo
NewGenIvf Group Limited (NIVF)
SYRS logo
Syros Pharmaceuticals (SYRS)
SPRC logo
SciSparc (SPRC)
TIVC logo
Tivic Health Systems (TIVC)
KRBP logo
Kiromic BioPharma (KRBP)
TOVX logo
Theriva Biologics (TOVX)
PSTV logo
Plus Therapeutics (PSTV)
Syra Health Corp Class A (SYRA)
SNOA logo
Sonoma Pharmaceuticals (SNOA)

FAQ

  • What is the ticker symbol for Centogene NV?
  • Does Centogene NV pay dividends?
  • What sector is Centogene NV in?
  • What industry is Centogene NV in?
  • What country is Centogene NV based in?
  • When did Centogene NV go public?
  • Is Centogene NV in the S&P 500?
  • Is Centogene NV in the NASDAQ 100?
  • Is Centogene NV in the Dow Jones?
  • When was Centogene NV's last earnings report?
  • When does Centogene NV report earnings?

What is the ticker symbol for Centogene NV?

The ticker symbol for Centogene NV is NASDAQ:CNTG

Does Centogene NV pay dividends?

No, Centogene NV does not pay dividends

What sector is Centogene NV in?

Centogene NV is in the Healthcare sector

What industry is Centogene NV in?

Centogene NV is in the Diagnostics & Research industry

What country is Centogene NV based in?

Centogene NV is headquartered in Germany

When did Centogene NV go public?

Centogene NV's initial public offering (IPO) was on November 7, 2019

Is Centogene NV in the S&P 500?

No, Centogene NV is not included in the S&P 500 index

Is Centogene NV in the NASDAQ 100?

No, Centogene NV is not included in the NASDAQ 100 index

Is Centogene NV in the Dow Jones?

No, Centogene NV is not included in the Dow Jones index

When was Centogene NV's last earnings report?

Centogene NV's most recent earnings report was on Sep 6, 2024

When does Centogene NV report earnings?

The date for Centogene NV's next earnings report has not been announced yet